Sirt3 Regulates Response to Oxidative Stress by Interacting with BER Proteins in Colorectal Cancer

J Kabzinski1, A Walczak1, I Majsterek1

  • 1Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Lodz, Poland.

Genetics Research
|April 20, 2022
PubMed

Insights

Mitochondrial Sirt3 protein regulates DNA repair proteins, protecting against oxidative damage in colorectal cancer. Targeting Sirt3 may enhance cancer therapy effectiveness by increasing cancer cell vulnerability.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Oxidative damage and unrepaired DNA damage are key factors in colorectal cancer (CRC) development.
  • Cells possess defense mechanisms, including nuclear and mitochondrial DNA repair systems, to counteract oxidative stress.

Purpose of the Study:

  • To investigate the role of mitochondrial Sirt3 in regulating DNA repair proteins involved in mitochondrial Base Excision Repair (mtBER).
  • To explore Sirt3's potential as a therapeutic target for enhancing colorectal cancer treatment.

Main Methods:

  • Investigated the regulatory relationship between Sirt3 and DNA repair proteins (NEIL1, NEIL2, MUTYH, APE1, LIG3) via deacetylation and physical interaction.
  • Assessed protein level alterations under oxidative stress in Sirt3-deprived cells.
  • Examined Sirt3's impact on apoptosis and cell survival rates.

Main Results:

  • Sirt3 regulates NEIL1, NEIL2, MUTYH, APE1, and LIG3 through deacetylation, controlling the mtBER pathway.
  • Sirt3 physically interacts with MUTYH, NEIL1, and APE1, confirming its regulatory role.
  • Depriving cells of Sirt3 leads to altered protein levels and impacts cell survival under oxidative stress.

Conclusions:

  • Sirt3 plays a crucial role in maintaining DNA integrity by regulating mtBER.
  • Sirt3 influences apoptosis and cell survival, suggesting its involvement in cancer progression.
  • Sirt3 is a potential therapeutic target to sensitize cancer cells to treatment, improving overall cancer therapy efficacy.

Related Concept Videos

Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Sulfur Assimilation01:20

Sulfur Assimilation

Sulfur is an essential element in biological systems, contributing to synthesizing key biomolecules, including amino acids such as cysteine and methionine, and cofactors such as coenzyme A and biotin. Microorganisms primarily assimilate sulfur as sulfate (SO₄²⁻) from the environment, which must undergo a series of biochemical transformations before it can be incorporated into cellular components. As sulfate is highly oxidized, it must undergo assimilatory sulfate reduction to...
96
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.1K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K